e-learning
resources
Barcelona 2010
Sunday, 19.09.2010
Immune responses for the diagnosis of tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
TB-specific Interferon-γ concentration after treatment of latent TB-infection
A. Nienhaus, J. Torres Costa, R. Silva, R. Sá, M. J. Cardoso (Porto, Portugal; Hamburg, Germany)
Source:
Annual Congress 2010 - Immune responses for the diagnosis of tuberculosis
Session:
Immune responses for the diagnosis of tuberculosis
Session type:
E-Communication Session
Number:
284
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Nienhaus, J. Torres Costa, R. Silva, R. Sá, M. J. Cardoso (Porto, Portugal; Hamburg, Germany). TB-specific Interferon-γ concentration after treatment of latent TB-infection. Eur Respir J 2010; 36: Suppl. 54, 284
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Cisplatin/pemetrexed chemotherapy versus palliative care survival in malignant pleural mesothelioma
Evaluating 17 years of latent tuberculosis infection screening in north-west England: a retrospective cohort study of reactivation
Lung function assessment in octogenarians with lung cancer diagnosis
Related content which might interest you:
Cost-effectiveness of interferon-γ release assay testing for the treatment of latent tuberculosis
Source: Eur Respir J 2007; 30: 321-332
Year: 2007
Latent TB screening before anti-TNFα treatment
Source: Annual Congress 2010 - Tuberculosis: metabolic insights
Year: 2010
IFN-γ response on T-cell based assays for the diagnosis of tuberculosis infection in rheumatic patients undergoing anti-TNF-α treatment
Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis
Year: 2009
Benefit of treatment of latent tuberculosis infection in individual patients
Source: Eur Respir J 2016; 47:1594-1595
Year: 2016
Benefit of treatment of latent tuberculosis infection in individual patients
Source: Eur Respir J 2016; 47:1592-1594
Year: 2016
Benefit of treatment of latent tuberculosis infection in individual patients
Source: Eur Respir J 2015; 46: 1397-1406
Year: 2015
Prevalence and treatment outcome of drug resistant pulmonary tuberculosis in HIV negative cases – experience from a tuberculosis treatment center in India
Source: Annual Congress 2009 - Multi/extensively-drug resistant tuberculosis
Year: 2009
Treatment of latent tuberculosis infection with 6 months isoniazid therapy in pediatric population
Source: Eur Respir J 2005; 26: Suppl. 49, 624s
Year: 2005
Diagnosis and treatment of latent tuberculosis infection
Source: Eur Respir Monogr 2018; 82: 381-398
Year: 2018
What is latent tuberculosis infection (LTBI)?
Source: Annual Congress 2009 - Microbial colonisation or latency: a foot in the door to respiratory infections
Year: 2009
Modulation of whole-blood IGRA response in patients with latent TB infection during treatment
Source: International Congress 2018 – Tuberculosis transmission and screening strategies
Year: 2018
The significance of the antigen-specific IFN-γ release assay
in vitro
for differential diagnosis between sarcoidosis and tuberculosis (TB) patients
Source: Annual Congress 2010 - What is new in the diagnosis of tuberculosis?
Year: 2010
Comparison of effector T-cell responses in patients with active TB disease compared to latent TB infection
Source: Annual Congress 2007 - New perspectives and old problems in diagnosing tuberculosis infection and disease
Year: 2007
Contribution of the T-SPOT.TB assay for differentiating active
versus
latent tuberculosis infection (LTBI)
Source: Annual Congress 2006 - New methods to diagnose tuberculosis infection
Year: 2006
Comparison of T-cell interferon-γ release assay to mycobacterium tuberculosis-specific antigens in patients with active and latent tuberculosis
Source: Annual Congress 2009 - Tuberculosis contact screening
Year: 2009
One year follow-up of T-SPOT. TB results in treated patients with active tuberculosis
Source: Annual Congress 2007 - New perspectives and old problems in diagnosing tuberculosis infection and disease
Year: 2007
Interferon-γ release assays for the diagnosis of latent tuberculosis infection in HIV-seropositive individuals
Source: Annual Congress 2008 - Interferon-gamma methods for the diagnosis of tuberculosis infection and disease
Year: 2008
A combinatorial dual-immunoassay predicts reactivation risk for patients with previously incomplete treatment for latent tuberculosis infection
Source: International Congress 2016 – Active and latent tuberculosis: biomarkers
Year: 2016
Outcomes of treatment of latent tuberculosis infection in children with two different regimens
Source: Eur Respir J 2006; 28: Suppl. 50, 487s
Year: 2006
Is neopterin concentration predictive in latent tuberculosis infection in health workers?
Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis I
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept